FDA Leadership Changes

News

FDA, Top Drug Regulator and Appoints Biotech Exec

FDA names former pharmaceutical company executive to oversee US drug program

The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the latest in a string of leadership changes at the agency. FDA Commissioner Marty Makary announced that Dr.

Politico · 2d

Makary ally named to key FDA drug post

Dr. George Tidmarsh, a Stanford pediatrics adjunct professor and former pharmaceutical executive, is FDA Commissioner Marty Makary’s pick to be the nation’s top drug regulator.

RealClearPolitics · 3d

FDA Appoints Biotech Exec as Top Drug Regulator

Marty Makary, commissioner of the FDA, is naming George Tidmarsh director of the Center for Drug Evaluation and Research.<br /> <br />

6hon MSN

100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar

Marty Makary says the FDA will plow ahead with big plans on ultra processed foods, dietary guidelines, and expedited drug and ...

13don MSNOpinion

FDA Commissioner: 100 Days of Change—Modernizing the FDA for a Healthier America | Opinion

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...

BioSpace1d

From Expertise to Empty Chairs: The FDA’s Self-Inflicted Crisis

While FDA Commissioner Marty Makary emphasizes learning and humility, the FDA has systematically removed the very experience ...

Benzinga.com2mon

New FDA Leadership Could Raise The Bar For Drug Approvals

New FDA Leadership Team: The FDA's top leadership has shifted under Commissioner Dr. Marty Makary, ... signals potential changes in FDA priorities and how the agency engages with biotech ...

KGW83mon

FDA tobacco regulator ousted as health agency shakes up leadership ...

The leadership vacuum comes as Kennedy moves to fire 3,500 FDA staffers and pushes ahead with plans to scrutinize ultra-processed foods, childhood vaccines, antidepressants and other long ...

BioSpace1d

FDA Opens Pilot Run of Commissioner Voucher Program

The FDA will select at most five companies that align with national priorities, including lower drug prices and increased ...

FDA Rejects Replimune’s Skin Cancer Treatment, Shares Sink

Replimune Group Inc. shares sank to their lowest point ever after US regulators rejected a skin cancer treatment from the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results